Mednax Inc
$ 22.29
-4.29%
04 Dec - close price
- Market Cap 2,028,191,000 USD
- Current Price $ 22.29
- High / Low $ 23.37 / 22.15
- Stock P/E 12.45
- Book Value 10.59
- EPS 1.87
- Next Earning Report 2026-02-19
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.07 %
- ROE 0.20 %
- 52 Week High 24.99
- 52 Week Low 11.84
About
Mednax, Inc. is a leading healthcare services provider specializing in neonatal, maternal-fetal, pediatric cardiology, and various pediatric subspecialties across the United States and Puerto Rico. Headquartered in Sunrise, Florida, the company is dedicated to delivering high-quality and compassionate care through a talented network of professionals, utilizing advanced medical practices to address the diverse needs of its patients. Mednax's unwavering commitment to clinical excellence and operational efficiency not only improves patient outcomes but also reinforces its vital position in the healthcare sector as demand for specialized pediatric services continues to rise.
Analyst Target Price
$22.67
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-10-30 | 2025-08-05 | 2025-05-05 | 2025-02-18 | 2024-11-01 | 2024-08-06 | 2024-05-07 | 2024-02-20 | 2023-11-02 | 2023-08-03 | 2023-05-02 | 2023-02-17 |
| Reported EPS | 0.67 | 0.53 | 0.2427 | 0.51 | 0.44 | 0.34 | 0.2 | 0.32 | 0.32 | 0.39 | 0.23 | 0.47 |
| Estimated EPS | 0.4379 | 0.42 | 0.2646 | 0.3646 | 0.37 | 0.31 | 0.19 | 0.33 | 0.43 | 0.4 | 0.23 | 0.48 |
| Surprise | 0.2321 | 0.11 | -0.0219 | 0.1454 | 0.07 | 0.03 | 0.01 | -0.01 | -0.11 | -0.01 | 0 | -0.01 |
| Surprise Percentage | 53.003% | 26.1905% | -8.2766% | 39.8793% | 18.9189% | 9.6774% | 5.2632% | -3.0303% | -25.5814% | -2.5% | 0% | -2.0833% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-19 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.4618 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: MD
2025-10-19 11:36:02
This article analyzes Pediatrix Medical Group Inc. (NYSE: MD) using AI models, highlighting a near-term strong sentiment transitioning to a neutral mid and long-term outlook. It identifies key signals, including a mid-channel oscillation pattern and an exceptional risk-reward short setup. The analysis provides specific institutional trading strategies and multi-timeframe signal analysis for MD.
2025-10-14 19:06:54
Pediatrix Medical Group (MD) is under investor scrutiny after reporting disappointing comparable store sales, raising concerns about demand and management decisions. While the stock has seen a sharp 9% drop recently, its 90-day and 1-year returns remain positive, suggesting long-term gains. Analysts currently view MD as 4% undervalued, with a fair value of $16.71, based on expected margin expansion and a lower future price-to-earnings multiple, though restructuring and fee negotiation uncertainties pose challenges.
2025-10-14 18:19:01
Pediatrix Medical Group (NYSE:MD) has seen a significant price increase and is currently considered a bargain according to a valuation model, with an intrinsic value of $24.08. The company's future outlook is optimistic, with expected earnings growth of 32% over the next few years, suggesting robust cash flows and higher share value. Investors are encouraged to consider the stock's undervaluation and growth prospects, along with other factors like management track record, before making investment decisions.
2025-10-12 08:41:15
Inspire Investing LLC has acquired a new stake in Pediatrix Medical Group, purchasing 64,120 shares valued at approximately $920,000. This move is part of a broader trend of increased institutional investment, with various firms significantly upping their holdings, leading to institutional investors owning 97.71% of the company's stock. Pediatrix Medical Group also reported strong quarterly earnings, beating analyst expectations with $0.53 EPS.
2025-08-25 00:00:00
Pediatrix Medical Group's stock has risen 35% over the past month, prompting an investigation into whether its fundamentals, particularly its Return on Equity (ROE), are driving this momentum. Despite an acceptable ROE of 13%, the company has experienced a 33% decline in net income over five years. Analysts, however, forecast a significant improvement in the company's earnings growth rate.
2024-12-31 23:59:59
Akron Children's Hospital is ending its contract with Pediatrix Medical Group, which supplies neonatologists for its Neonatal Intensive Care Unit (NICU), effective next March. This "business decision" means the hospital will move to a new model, likely hiring neonatologists directly. The change also affects NICU services at Cleveland Clinic Akron General, which plans to staff its NICU with its own doctors starting November 1.
